Suppr超能文献

下肢经皮腔内血管成形术后全身输注尿激酶对晚期严重肢体缺血患者肢体挽救率的影响。

Effect of systemic urokinase infusion after lower limb percutaneous transluminal angioplasty on limb salvage rate in patients with late-stage critical limb ischemia.

作者信息

Yen H-T, Hsieh M-J, Wu C-C, Lee F-Y

机构信息

Division of Cardiovascular Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Division of Cardiovascular Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

出版信息

Eur J Vasc Endovasc Surg. 2014 Oct;48(4):414-22. doi: 10.1016/j.ejvs.2014.04.006. Epub 2014 Jun 28.

Abstract

OBJECTIVE

To evaluate the effect of systemically administered urokinase (UK) after percutaneous transluminal angioplasty with or without stent (PTA ± stent) on the reduction in the rate and level of amputation in patients with critical limb ischemia (CLI) with tissue loss.

METHODS

This was an observational, nonrandomized, retrospective study of 183 Taiwanese patients with Rutherford stage 5 or 6, and Fontaine stage 4 lower extremity CLI. Patients received either PTA ± stent or PTA ± stent + UK infusion (250,000 IU, daily for 5 days). PTA of the iliac, femoral, anterior tibial artery, posterior tibial artery, and peroneal arteries was included. Amputation was classified as minor, with direct wound healing, and minor amputation or surgical debridement of toes and major, with below- (BKA) and above-knee amputation (AKA).

RESULTS

In groups of patients with comparable baseline characteristics, 85 and 90 patients received PTA ± stent and PTA ± stent + UK, respectively. There were 24 major limb amputations performed. A significant majority (20/24 (83.3%) were performed in patients who did not receive adjuvant urokinase, compared with 4/24 (16.7%) of patients who did receive urokinase (p = 0.000287). There was a significant increase in the limb salvage rate for infrapopliteal lesions in patients treated with PTA + UK (12/72 with UK; 60/72 without UK; p ≤ .0001). Intracranial hemorrhage (n = 1) and bleeding at the inguinal puncture site (n = 2) were reported in the PTA ± stent + UK group. Eight deaths (one in the PTA ± stent + UK group; seven in the PTA ± stent) occurred during the study.

CONCLUSION

Systemic administration of UK with the PTA ± stent procedure may reduce the requirement for major amputation in patients with CLI with tissue loss (Rutherford 5 or 6). The difference is more pronounced in patients undergoing infrapopliteal interventions. However, these findings need to be confirmed in a randomized prospective study.

摘要

目的

评估在经皮腔内血管成形术(无论是否置入支架,即PTA±支架)后全身应用尿激酶(UK)对伴有组织缺损的严重肢体缺血(CLI)患者截肢率和截肢水平降低的影响。

方法

这是一项对183例台湾地区处于卢瑟福分级5或6级、Fontaine分级4级的下肢CLI患者进行的观察性、非随机、回顾性研究。患者接受PTA±支架治疗或PTA±支架+UK输注治疗(250,000国际单位,每日1次,共5天)。治疗包括对髂动脉、股动脉、胫前动脉、胫后动脉和腓动脉进行PTA。截肢分为小截肢(直接伤口愈合、足趾小截肢或手术清创)和大截肢(膝下截肢(BKA)和膝上截肢(AKA))。

结果

在基线特征可比的患者组中,分别有85例和90例患者接受了PTA±支架治疗和PTA±支架+UK治疗。共进行了24例大肢体截肢。绝大多数(24例中的20例(83.3%))发生在未接受辅助尿激酶治疗的患者中,而接受尿激酶治疗的患者为24例中的4例(16.7%)(p = 0.000287)。接受PTA+UK治疗的患者腘动脉以下病变的肢体挽救率显著提高(接受UK治疗的患者中72例有12例;未接受UK治疗的患者中72例有60例;p≤0.0001)。PTA±支架+UK组报告了1例颅内出血和2例腹股沟穿刺部位出血。研究期间发生了8例死亡(PTA±支架+UK组1例;PTA±支架组7例)。

结论

在PTA±支架手术中全身应用UK可能会降低伴有组织缺损的CLI患者(卢瑟福分级5或6级)的大截肢需求。这种差异在接受腘动脉以下介入治疗的患者中更为明显。然而,这些发现需要在随机前瞻性研究中得到证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验